A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma

LESSONS LEARNED. Pazopanib shows a modest efficacy in metastatic alveolar soft part sarcoma. Clinical outcomes were comparable to those in previous studies using antiangiogenic drugs. Further prospective studies evaluating the benefit of pazopanib in alveolar soft part sarcoma with a larger sample a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Kim, Miso, Kim, Tae Min, Keam, Bhumsuk, Kim, Yu Jung, Paeng, Jin Chul, Moon, Kyung Chul, Kim, Dong‐Wan, Heo, Dae Seog
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2018
Teme:
Clinical Trial Results
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324645/
https://ncbi.nlm.nih.gov/pubmed/30254189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0464
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki